共 4 条
To all involved - we have a problem
被引:3
作者:

不详
论文数: 0 引用数: 0
h-index: 0
机构: Nature Reviews Clinical Oncology,
机构:
[1] Nature Reviews Clinical Oncology,
关键词:
APPROVALS;
D O I:
10.1038/s41571-018-0052-9
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
引用
收藏
页码:397 / 397
页数:1
相关论文
共 4 条
[1]
2017 FDA drug approvals: number rebounds but average value slips
[J].
Baedeker, Mathias
;
Ringel, Michael
;
Panier, Valery
;
Schulze, Ulrik
.
NATURE REVIEWS DRUG DISCOVERY,
2018, 17 (02)
:87-87

Baedeker, Mathias
论文数: 0 引用数: 0
h-index: 0
机构:
Boston Consulting Grp Inc, Ludwigstr 21, D-80539 Munich, Germany Boston Consulting Grp Inc, Ludwigstr 21, D-80539 Munich, Germany

Ringel, Michael
论文数: 0 引用数: 0
h-index: 0
机构:
Boston Consulting Grp Inc, Exchange Pl,31st Floor, Boston, MA 02109 USA Boston Consulting Grp Inc, Ludwigstr 21, D-80539 Munich, Germany

Panier, Valery
论文数: 0 引用数: 0
h-index: 0
机构:
Boston Consulting Grp Inc, Exchange Pl,31st Floor, Boston, MA 02109 USA Boston Consulting Grp Inc, Ludwigstr 21, D-80539 Munich, Germany

Schulze, Ulrik
论文数: 0 引用数: 0
h-index: 0
机构:
Boston Consulting Grp Inc, Munstergasse 2, CH-8001 Zurich, Switzerland Boston Consulting Grp Inc, Ludwigstr 21, D-80539 Munich, Germany
[2]
Approvals in 2016: questioning the clinical benefit of anticancer therapies
[J].
Booth, Christopher M.
;
Del Paggio, Joseph C.
.
NATURE REVIEWS CLINICAL ONCOLOGY,
2017, 14 (03)
:135-136

Booth, Christopher M.
论文数: 0 引用数: 0
h-index: 0
机构:
Queens Univ, Dept Oncol Sci, Univ Ave, Kingston, ON K7L 3N6, Canada
Queens Univ, Dept Publ Hlth Sci, Univ Ave, Kingston, ON K7L 3N6, Canada Queens Univ, Dept Oncol Sci, Univ Ave, Kingston, ON K7L 3N6, Canada

Del Paggio, Joseph C.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Toronto, Div Med Oncol, Dept Med, Kings Coll Circus, Toronto, ON M5S, Canada Queens Univ, Dept Oncol Sci, Univ Ave, Kingston, ON K7L 3N6, Canada
[3]
Low-value approvals and high prices might incentivize ineffective drug development
[J].
Prasad, Vinay
;
McCabe, Christopher
;
Mailankody, Sham
.
NATURE REVIEWS CLINICAL ONCOLOGY,
2018, 15 (07)
:399-400

Prasad, Vinay
论文数: 0 引用数: 0
h-index: 0
机构:
Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol Oncol, Portland, OR 97201 USA
Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA
Oregon Hlth & Sci Univ, Ctr Hlth Care Eth, Portland, OR 97201 USA Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol Oncol, Portland, OR 97201 USA

McCabe, Christopher
论文数: 0 引用数: 0
h-index: 0
机构:
Inst Hlth Econ, Edmonton, AB, Canada Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol Oncol, Portland, OR 97201 USA

Mailankody, Sham
论文数: 0 引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol Oncol, Portland, OR 97201 USA
[4]
Sustainability and affordability of cancer drugs: a novel pricing model
[J].
Uyl-de Groot, Carin A.
;
Lowenberg, Bob
.
NATURE REVIEWS CLINICAL ONCOLOGY,
2018, 15 (07)
:405-406

Uyl-de Groot, Carin A.
论文数: 0 引用数: 0
h-index: 0
机构:
Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands
Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands

Lowenberg, Bob
论文数: 0 引用数: 0
h-index: 0
机构:
Erasmus Univ, Med Ctr, Dept Haematol, Rotterdam, Netherlands Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands